Background: C3G and ic-MPGN are complement-mediated rare kidney disorders with variable responsiveness to standard immunosuppressive protocols. Information regarding biomarkers of therapeutic responsiveness is scarce. ERKReg, a longitudinal pan-European registry for rare kidney diseases is currently...
No comments yet
Be the first to share your thoughts!